Test validation

The automated validation system for your NGS tests. omnomicsQ provides functionality to facilitate test optimisation, familiarisation, and validation processes to be used before and during the formal process of assay validation. Physical samples for which well-curated, known variant data is available are subject to the NGS test under different conditions and the obtained results are compared to the known data in a concordance analysis. True positive, false positive, and false negative hits are scored in an automatic fashion. Summary reporting allows to address issues along the test process and provides indications on among other reportable range or limits of detection as well as thresholds for sample quality parameters.

Sample quality

The quality management system for your NGS workflows. omnomicsQ provides the first line of defence against quality issues at all stages of your laboratory’s data analysis. Validate tests, check precision, sensitivity, and level of detection; monitor coverage of technical and clinical targets, define requirement thresholds for SOPs and optimise workflows. For every sample, adhere to SOPs, benchmark progress, compare to peers, report and chart. Integrate into your existing bioinformatics pipeline or laboratory information system, operate automatically or through the graphical user interface, provide oversight of the laboratory activity, and meet regulatory requirements.

Interpretation

The CE-marked software platform for variant annotation and reporting on patient NGS data. omnomicsNGS is the place that provides all the relevant genomic and variant information for independent clinicians and molecular genetics laboratories based on patient data, growing local knowledge, and external information sources. Report quickly for gene panels according to ACMG and ASCO guidelines or dig deep for rare genetic disorders in whole exomes or genomes. Use it on the cloud, as local stand-alone or integrate it into larger IT infrastructures for clinical oncology or other genetic testing, for clinical research projects or together with a biobank as the repository for genomic variants.

News